Cargando…
Sulfonylurea and neuroprotection: The bright side of the moon
Sulfonylurea (SUR) agents are the second and most used oral hypoglycemic drugs after metformin and they still as an imperative tool for most favorable of glucose control. SURs are used mainly in the management of Type 2 diabetes mellitus since; they are effective in the glycemic control and reductio...
Autores principales: | Hussien, Nawar R., Al-Naimi, Marwa S., Rasheed, Huda A., Al-kuraishy, Hayder M., Al-Gareeb, Ali I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6302683/ https://www.ncbi.nlm.nih.gov/pubmed/30637228 http://dx.doi.org/10.4103/japtr.JAPTR_317_18 |
Ejemplares similares
-
Nephrotoxicity: Role and significance of renal biomarkers in the early detection of acute renal injury
por: Al-Naimi, Marwa S., et al.
Publicado: (2019) -
Levothyroxine improves Paraoxonase (PON-1) serum levels in patients with primary hypothyroidism: Case–control study
por: Al-Naimi, Marwa S., et al.
Publicado: (2018) -
New insight into the effect of lycopene on the oxidative stress in acute kidney injury
por: Rasheed, Huda A., et al.
Publicado: (2020) -
Effects of diabetic pharmacotherapy on prolactin hormone in patients with type 2 diabetes mellitus: Bane or Boon
por: Rasheed, Huda Abdulbaki, et al.
Publicado: (2019) -
Involvement of orexinergic system in psychiatric and neurodegenerative disorders: A scoping review
por: Al-Kuraishy, Hayder M., et al.
Publicado: (2020)